Studies on the metal binding sites in the catalytic domain of β1,4-galactosyltransferase

被引:47
作者
Boeggeman, E
Qasba, PK
机构
[1] NCI CCR, Struct Glycobiol Sect, Frederick, MD 21702 USA
[2] NCI CCR, Intramural Res Support Program, SAIC, Lab Expt & Computat Biol, Frederick, MD 21702 USA
关键词
aspartate motifs; bovine beta 4Gal-T1; catalytic domain; metal-binding sites; substrate binding;
D O I
10.1093/glycob/cwf045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The catalytic domain of bovine beta1,4-galactosyltransferase (beta4Gal-T1) has been shown to have two metal binding sites, each with a distinct binding affinity. Site I binds Mn2+ with high affinity and does not bind Ca2+, whereas site II binds a variety of metal ions, including Ca2+. The catalytic region of beta4Gal-T1 has DXD motifs, associated with metal binding in glycosyltransferases, in two separate sequences: (DYDYNCFVFSDVD254)-Y-242 (region I) and W(312)GWGGEDDD(320) (region II). Recently, the crystal structure of beta4Gal-T1 bound with UDP, Mn2+, and alpha-lactalbumin was determined in our laboratory. It shows that in the primary metal binding site of beta4Gal-T1, the Mn2+ ion, is coordinated to five ligands, two supplied by the phosphates of the sugar nucleotide and the other three by Asp254, His347, and Met344. The residue Asp254 in the (DVD254)-V-252 sequence in region I is the only residue that is coordinated to the Min(2+) ion. Region II forms a loop structure and contains the (EDDD320)-D-317 sequence in which residues Asp318 and Asp319 are directly involved in GlcNAc binding. This study, using site-directed mutagenesis, kinetic, and binding affinity analysis, shows that Asp254 and His347 are strong metal ligands, whereas Met344, which coordinates less strongly, can be substituted by alanine or glutamine. Specifically, substitution of Met344 to Gln has a less severe effect on the catalysis driven by Co2+. Glu317 and Asp320 mutants, when partially activated by Mn2+ binding to the primary site, can be further activated by Co2+ or inhibited by Ca2+, an effect that is the opposite of what is observed with the wild-type enzyme.
引用
收藏
页码:395 / 407
页数:13
相关论文
共 48 条
[1]   Cloning and expression of a proteoglycan UDP-galactose:β-xylose β1,4-galactosyltransferase I -: A seventh member of the human β4-galactosyltransferase gene family [J].
Almeida, R ;
Levery, SB ;
Mandel, U ;
Kresse, H ;
Schwientek, T ;
Bennett, EP ;
Clausen, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (37) :26165-26171
[2]   A family of human β4-galactosyltransferases -: Cloning and expression of two novel UDP-galactose:: β-N-acetylglucosamine β1,4-galactosyltransferases, β4Gal-T2 and β4Gal-T3 [J].
Almeida, R ;
Amado, M ;
David, L ;
Levery, SB ;
Holmes, EH ;
Merkx, G ;
van Kessel, AG ;
Rygaard, E ;
Hassan, H ;
Bennett, E ;
Clausen, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) :31979-31991
[3]   Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions [J].
Amado, M ;
Almeida, R ;
Schwientek, T ;
Clausen, H .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1473 (01) :35-53
[4]   ANALYSIS OF THE SUBSTRATE BINDING-SITES OF HUMAN GALACTOSYLTRANSFERASE BY PROTEIN ENGINEERING [J].
AOKI, D ;
APPERT, HE ;
JOHNSON, D ;
WONG, SS ;
FUKUDA, MN .
EMBO JOURNAL, 1990, 9 (10) :3171-3178
[5]  
Ausubel F. M., 1999, SHORT PROTOCOLS MOL
[6]   CRYSTAL-STRUCTURE OF A COMPLEX BETWEEN SERRATIA-MARCESCENS METALLOPROTEASE AND AN INHIBITOR FROM ERWINIA-CHRYSANTHEMI [J].
BAUMANN, U ;
BAUER, M ;
LETOFFE, S ;
DELEPELAIRE, P ;
WANDERSMAN, C .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 248 (03) :653-661
[7]  
BELL JE, 1976, J BIOL CHEM, V251, P3003
[8]  
BOEGGEMAN E, 1998, FASEB J, V12, P8
[9]   FUNCTIONAL DOMAINS OF BOVINE BETA-1,4 GALACTOSYLTRANSFERASE [J].
BOEGGEMAN, EE ;
BALAJI, PV ;
QASBA, PK .
GLYCOCONJUGATE JOURNAL, 1995, 12 (06) :865-878
[10]   EXPRESSION OF DELETION CONSTRUCTS OF BOVINE BETA-1,4-GALACTOSYLTRANSFERASE IN ESCHERICHIA-COLI - IMPORTANCE OF CYS134 FOR ITS ACTIVITY [J].
BOEGGEMAN, EE ;
BALAJI, PV ;
SETHI, N ;
MASIBAY, AS ;
QASBA, PK .
PROTEIN ENGINEERING, 1993, 6 (07) :779-785